Upstream response element gene transcriptions: Difference between revisions

Jump to navigation Jump to search
Line 62: Line 62:


"In the case of the 𝛂􏰁-gene, modifications in the CRE sequence and in adjacent upstream regulatory elements appear to account for the ability of the 𝛂􏰁-gene to be expressed in the placenta as well as in the pituitary gland (17, 18)."<ref name=Johnson/> The term ''upstream regulatory element'' refers to the general situation while ''upstream response element'' refers to a specific element.
"In the case of the 𝛂􏰁-gene, modifications in the CRE sequence and in adjacent upstream regulatory elements appear to account for the ability of the 𝛂􏰁-gene to be expressed in the placenta as well as in the pituitary gland (17, 18)."<ref name=Johnson/> The term ''upstream regulatory element'' refers to the general situation while ''upstream response element'' refers to a specific element.
"Nrf2 binds an upstream response element in the frataxin locus, and the anesthetic dyclonine has been shown to activate Nrf2, increase the mRNA and protein levels of frataxin and rescue frataxin‐dependent enzyme deficiencies in the iron‐sulfur enzymes aconitase and succinate dehydrogenase [54]."<ref name=Kostova>{{ cite journal
|author=Albena T. Dinkova‐Kostova, Rumen V. Kostov and Aleksey G. Kazantsev
|title=The role of Nrf2 signaling in counteracting neurodegenerative diseases
|journal=The FEBS Journal
|date=11 January 2018
|volume=285
|issue=19
|pages=
|url=https://febs.onlinelibrary.wiley.com/doi/full/10.1111/febs.14379
|arxiv=
|bibcode=
|doi=10.1111/febs.14379
|pmid=
|accessdate=21 August 2020 }}</ref>
The "Nrf2-sMaf heterodimer recognizes DNA sequences referred to as the antioxidant/electrophile responsive element (ARE/EpRE)".<ref name=Otsuki>{{ cite journal
|author=Akihito Otsuki, Mikiko Suzuki, Fumiki Katsuoka, Kouhei Tsuchida, Hiromi Suda, Masanobu Morita, Ritsuko Shimizu, MasayukiYamamoto
|title=Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection
|journal=Free Radical Biology and Medicine
|date=February 2016
|volume=91
|issue=
|pages=45-57
|url=https://www.sciencedirect.com/science/article/abs/pii/S0891584915011478
|arxiv=
|bibcode=
|doi=10.1016/j.freeradbiomed.2015.12.005
|pmid=
|accessdate=21 August 2020 }}</ref> "We have compared these binding sequences and found that they show a common consensus sequence, 5′-(A/G)TGA(G/C)nnnGC-3′, but these recognition elements are partially distinct from the element bound by Maf homodimers."<ref name=Otsuki/>


==Acknowledgements==
==Acknowledgements==

Revision as of 00:29, 22 August 2020

Editor-In-Chief: Henry A. Hoff

"Apolipoprotein E (apoE)1 is a major component of various classes of plasma lipoproteins. It is a single-chain polypeptide of 299 amino acids, which plays a prominent role in transport and metabolism of plasma cholesterol and triglycerides, resulting from its ability to interact with lipoprotein receptors (1). The amino acid sequence of the human protein presents two polymorphic sites that generate three isoforms (apoE2, apoE3, and apoE4)."[1]

"URE1 and URE3, upstream response elements 1 and 3 (24, 28)" occur within -163 to -124 and -113 to -80, respectively, and a TATA box within -38 to about -30 nts "of the proximal APOE promoter".[1]

An "unidentified protein was reported to bind to URE3 between -89 and -101 (28)."[1]

"To identify specific sequences in the 5'-flanking region that are significant for human apoE gene expression, portions of the 5‘ ends of this region were progressively deleted by Bal31 nuclease treatment. [...] In both CHO and HepG2 cells, deletion of the 268 nucleotides between -651 and -383, which contains part of an AluI sequence, had little effect on apoE promoter-directed CAT activity. Deletion of the region between nucleotides -383 and -212 resulted in almost a 2-fold reduction in CAT activity. This region contains two types of directly repeated elements: 5‘-TCCAGAT-3’ (-355 to -349, -335 to -329, and -268 to -262) and 5’-CAGGAAAGGA-3’ (-312 to -303 and -296 to -287). In addition, this region contains the hexanucleotide core sequences of an Spl protein binding "GC box" (-279 to -274) (36), but the identities of the neighboring nucleotides indicate that it may be a low affinity binding site (37). Deletion of the sequence between nucleotides -212 and -81 resulted in about a 4-fold reduction in CAT activity in both cell types. The removal of the region between nucleotides -81 and -39 resulted in another 2.5-4-fold reduction in promoter activity. Since this region contains two GC boxes, these results suggest that one or both GC boxes are functional components of the apoE promoter complex. Deletion of the region from nucleotides -39 to -14, which contains a consensus TATA box element, results in an additional 6- to 10-fold decrease in activity. In summary, the results from these deletion studies with the chimeric CAT gene suggest that, in addition to the TATA box in the proximal 383 nucleotides of the 5’-flanking region of human apoE gene at least three different domains, possibly containing several elements, are involved in the regulation of its transcription."[2]

There "are three elements with enhancer-like properties located within this 1-kb fragment. One element, termed upstream regulatory element 2 (URE2), is located between residues -366 and -246. Another element, termed upstream regulatory element 1 (UREl), was found in a fragment located between residues -246 and -81; UREl is located within a 69-bp segment between residues -193 and -124 of this fragment. The third element, termed intron regulatory element1 (IREl), was found within the first intron and is located in a 219-bp segment between residues +44 and +262. These three elements had promoter-enhancing activity in both orientations."[2]

URE1 is apparently 5'-ACCTCTATGCCCCACCTCCTTC-3' or contained in it between -193 to -124.[2] URE2 is apparently contained in -366 to -246.[2]

URE1 may be 5‘-AGGAG(G/C)(T/G)GGGG(C/T)-3'.[2]

"The sequence of the URE1 protein binding region [...] contains inverted repeated sequences (-164 to -159, -152 to -147, 5‘-ACCTCTATGCCCCACCTCCTTC-3’)."[2]

Upstream response or regulatory elements

"In the [gonadotropin] 􏰁𝛂-gene, two identical repeats of a consensus cAMP response element (CRE) are located between -􏰇146 and -􏰇111 bp of the promoter (10–12). These CREs bind cAMP response element-binding protein (12–14) along with other members of the B-Zip family of transcription factors (15, 16). An adjacent element, termed the upstream response element (URE, -􏰇180 to 􏰇-151), also contributes to basal expression and appears to contribute to placenta-specific expression of the 􏰁𝛂-promoter (12, 13, 17–20). The URE contains three overlapping protein binding sites referred to as the trophoblast-specific element (TSE, or URE2 (􏰇-187 to -􏰇159)) (12, 13, 18, 21), downstream domain (-􏰇172 to -􏰇151) (13, 19), and GATA (𝛂􏰁-ACT, URE1) (-􏰇165 to -􏰇140) (22). Protein binding to the TSE and downstream domain are mutually exclusive (13, 19)."[3]

"In the case of the 𝛂􏰁-gene, modifications in the CRE sequence and in adjacent upstream regulatory elements appear to account for the ability of the 𝛂􏰁-gene to be expressed in the placenta as well as in the pituitary gland (17, 18)."[3] The term upstream regulatory element refers to the general situation while upstream response element refers to a specific element.

"Nrf2 binds an upstream response element in the frataxin locus, and the anesthetic dyclonine has been shown to activate Nrf2, increase the mRNA and protein levels of frataxin and rescue frataxin‐dependent enzyme deficiencies in the iron‐sulfur enzymes aconitase and succinate dehydrogenase [54]."[4]

The "Nrf2-sMaf heterodimer recognizes DNA sequences referred to as the antioxidant/electrophile responsive element (ARE/EpRE)".[5] "We have compared these binding sequences and found that they show a common consensus sequence, 5′-(A/G)TGA(G/C)nnnGC-3′, but these recognition elements are partially distinct from the element bound by Maf homodimers."[5]

Acknowledgements

The content on this page was first contributed by: Henry A. Hoff.

Initial content for this page in some instances came from Wikiversity.

See also

References

  1. 1.0 1.1 1.2 Enrique Salero, Raquel Pérez-Sen, Jun Aruga, Cecilio Giménez, and Francisco Zafra (19 January 2001). "Transcription Factors Zic1 and Zic2 Bind and Transactivate the Apolipoprotein E Gene Promoter" (PDF). The Journal of Biological Chemistry. 276 (3): 1881–1888. doi:10.1074/jbc.M007008200. Retrieved 9 December 2018.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Young-Ki Paik, David J. Chang, Catherine A. Reardon, Michael D. Walker, Ellen Taxman, and John M. Taylor (15 September 1988). "Identification and Characterization of Transcriptional Regulatory Regions Associated with Expression of the Human Apolipoprotein E Gene" (PDF). The Journal of Biological Chemistry. 263 (26): 13340–13349. Retrieved 9 December 2018.
  3. 3.0 3.1 Wade Johnson, Chris Albanese, Stuart Handwerger, Trevor Williams􏰃, Richard G. Pestell, and J. Larry Jameson (13 June 1997). "Regulation of the Human Chorionic Gonadotropin 􏰁𝛂- and 􏰂𝛃-Subunit Promoters by AP-2" (PDF). The Journal of Biological Chemistry. 272 (24): 15405–15412. doi:10.1074/jbc.272.24.15405. Retrieved 21 August 2020.
  4. Albena T. Dinkova‐Kostova, Rumen V. Kostov and Aleksey G. Kazantsev (11 January 2018). "The role of Nrf2 signaling in counteracting neurodegenerative diseases". The FEBS Journal. 285 (19). doi:10.1111/febs.14379. Retrieved 21 August 2020.
  5. 5.0 5.1 Akihito Otsuki, Mikiko Suzuki, Fumiki Katsuoka, Kouhei Tsuchida, Hiromi Suda, Masanobu Morita, Ritsuko Shimizu, MasayukiYamamoto (February 2016). "Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection". Free Radical Biology and Medicine. 91: 45–57. doi:10.1016/j.freeradbiomed.2015.12.005. Retrieved 21 August 2020.

External links

Template:Sisterlinks